Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Benziane-Ouaritini

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
JAMA Oncology|August 8, 2024
Hypofractionated Postprostatectomy Radiotherapy-Less is Really More?Nicolas Benziane-Ouaritini, Thomas Zilli, Paul Sargos
International Journal of Radiation Oncology, Biology, Physics|September 6, 2025
Hypofractionated Radiation Therapy for Prostate Cancer in the Postoperative Setting: Is It Capable of Going the Distance?Vérane Achard, Nicolas Benziane-Ouaritini, Paul Sargos
European Urology Focus|October 27, 2024
Local Treatment (Primary Tumor and Metastases) in Metastatic Prostate CancerNicolas Benziane-Ouaritini, Alberto Bossi, Paul Sargos
Journal of Contemporary Brachytherapy|November 11, 2021
Brachytherapy for oligometastatic prostate cancer to the penisNicolas Martz, Nicolas Benziane-Ouaritini, Mathieu Gautier, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|June 23, 2024
Organ at risk dose-volume metrics in a series of hypofractionated breast radiotherapy with integrated boostVincent Vinh-Hung, Nicolas Benziane-Ouaritini, Sarah Belhomme, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 19, 2024
Emergency radiation therapy in modern-day practice: Now or never, or never again ?Margaux Yaouanq, Nyere Gibson, Augustin Boudoussier, et al.
The French Journal of Urology|June 1, 2024
Stereotactic body radiation therapy for primary renal cell carcinoma: A review on behalf of the CC-AFURita Bentahila, Karim Bensalah, Nicolas Benziane-Ouaritini, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 11, 2025
Role of radiotherapy in the management of primary renal cell carcinoma: Recommendations from the Société française de radiothérapie oncologique (SFRO, the French society for radiation oncology)Nicolas Benziane-Ouaritini, Jennifer Le Guevelou, Stéphane Supiot, et al.
European Urology Oncology|May 16, 2024
Short-term Darolutamide (ODM-201) Concomitant to Radiation Therapy for Patients with Unfavorable Intermediate-risk Prostate Cancer: The Darius (AFU-GETUG P15) Phase 2 Trial ProtocolPaul Sargos, Carine Bellera, Rita Bentahila, et al.
Frontiers in Oncology|December 9, 2021
Post-Operative Radiotherapy in Prostate Cancer: Is It Time for a Belt and Braces Approach?Nicolas Giraud, Nicolas Benziane-Ouaritini, Ulrike Schick, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
JAMA Oncology|August 8, 2024
Hypofractionated Postprostatectomy Radiotherapy-Less is Really More?Nicolas Benziane-Ouaritini, Thomas Zilli, Paul Sargos
International Journal of Radiation Oncology, Biology, Physics|September 6, 2025
Hypofractionated Radiation Therapy for Prostate Cancer in the Postoperative Setting: Is It Capable of Going the Distance?Vérane Achard, Nicolas Benziane-Ouaritini, Paul Sargos
European Urology Focus|October 27, 2024
Local Treatment (Primary Tumor and Metastases) in Metastatic Prostate CancerNicolas Benziane-Ouaritini, Alberto Bossi, Paul Sargos
Journal of Contemporary Brachytherapy|November 11, 2021
Brachytherapy for oligometastatic prostate cancer to the penisNicolas Martz, Nicolas Benziane-Ouaritini, Mathieu Gautier, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|June 23, 2024
Organ at risk dose-volume metrics in a series of hypofractionated breast radiotherapy with integrated boostVincent Vinh-Hung, Nicolas Benziane-Ouaritini, Sarah Belhomme, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 19, 2024
Emergency radiation therapy in modern-day practice: Now or never, or never again ?Margaux Yaouanq, Nyere Gibson, Augustin Boudoussier, et al.
The French Journal of Urology|June 1, 2024
Stereotactic body radiation therapy for primary renal cell carcinoma: A review on behalf of the CC-AFURita Bentahila, Karim Bensalah, Nicolas Benziane-Ouaritini, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 11, 2025
Role of radiotherapy in the management of primary renal cell carcinoma: Recommendations from the Société française de radiothérapie oncologique (SFRO, the French society for radiation oncology)Nicolas Benziane-Ouaritini, Jennifer Le Guevelou, Stéphane Supiot, et al.
European Urology Oncology|May 16, 2024
Short-term Darolutamide (ODM-201) Concomitant to Radiation Therapy for Patients with Unfavorable Intermediate-risk Prostate Cancer: The Darius (AFU-GETUG P15) Phase 2 Trial ProtocolPaul Sargos, Carine Bellera, Rita Bentahila, et al.
Frontiers in Oncology|December 9, 2021
Post-Operative Radiotherapy in Prostate Cancer: Is It Time for a Belt and Braces Approach?Nicolas Giraud, Nicolas Benziane-Ouaritini, Ulrike Schick, et al.
Pageof 2